Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
Background. Doxorubicin (DOX) is one of the most potent and widely prescribed antitumor agents; however, its clinical use is limited by cardiac side effects. In this study, we aimed to clarify the protective effects of Qiliqiangxin (QL), a traditional Chinese medicine formulation, on DOX-induced car...
Saved in:
| Main Authors: | Yating Qin, Chao Lv, Xinxin Zhang, Weibin Ruan, Xiangyu Xu, Chen Chen, Xiaoning Wan, Xinyun Ji, Juan Zhou, Li Lu, Xiaomei Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2022/9926635 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isoquercitrin Suppresses Esophageal Squamous Cell Carcinoma (ESCC) by Inducing Excessive Autophagy and Promoting Apoptosis via the AKT/mTOR Signaling Pathway
by: Zhibin Liu, et al.
Published: (2025-06-01) -
Current Understanding and Evidence Regarding Qiliqiangxin (QLQX) in Heart Failure Treatment: From Basic to Clinical Research
by: Iokfai Cheang, et al.
Published: (2025-03-01) -
Excessive Autophagy Activation and Increased Apoptosis Are Associated with Palmitic Acid-Induced Cardiomyocyte Insulin Resistance
by: Shanxin Li, et al.
Published: (2017-01-01) -
Research on the mechanism of the anti-myocardial infarction effect of the Qiliqiangxin capsule on heart failure rats via nontargeted metabolomics and lipidomics
by: Kuangyi Liu, et al.
Published: (2024-12-01) -
Silymarin plus doxorubicin exerts the anti-hepatocellular carcinoma effects via Wnt, apoptosis, autophagy and angiogenesis pathways
by: Baohong Yuan, et al.
Published: (2025-06-01)